This message was sent to ##Email##
|
|
|
|
|
ASPET
In the latest PharmTalk Blog post, Dr. Myron L. Toews introduces postdocs and young faculty to the weekly email newsletter from NIAID (National Institutes of Allergy and Infectious Diseases), the NIAID Funding News.
READ NOW
ASPET
After the House Budget Committee Republicans met earlier this month in another attempt to seek out common ground on a budget resolution, it still remains unclear as to whether they are close to passing a budget for FY 2017.
READ MORE
ASPET
The Senate Health, Education, Labor and Pensions (HELP) Committee approved the final biomedical innovation bills that form its counterpart to the 21st Century Cures Act.
READ MORE
ASPET
The Agency for Health Research and Quality (AHRQ) selected Dr. Andrew Bindman as its new Director. Dr. Bindman started his new position on May 2nd.
READ MORE
ASPET
To connect students with education and training opportunities in STEM fields, the U.S. Department of Energy, in collaboration with participating agencies in the National Science and Technology Council's Committee on STEM Education and the Science.gov Alliance, launched two new federal interagency websites on Science.gov: STEMUndergrads.science.gov and STEMGradStudents.science.gov.
LEARN MORE
ASPET
The manuscript submission system for ASPET's journals, BenchPress, now provides a new drag-and-drop interface that makes it faster to upload files during submission.
LEARN MORE
ASPET
Scott Waldman, MD, PhD, is a professor and chair of the department of pharmacology and experimental therapeutics at Thomas Jefferson University. He is trained in internal medicine and clinical pharmacology.
READ MORE
ASPET
Dr. Crowe received his MD from the University of North Carolina at Chapel Hill, and conducted five years of post-doctoral training in Dr. Robert Chanock's laboratory at the National Institute of Allergy and Infectious Diseases (NIAID).
READ MORE
ASPET
In 2012, Atul Laddu, MD, PhD, founded the Georgia Thrombosis Forum, an affiliate of North American Thrombosis Forum. Since then, he has been working with a team of volunteers to promote awareness of the fatal conditions of deep vein thrombosis and pulmonary embolism in the state of Georgia.
READ MORE
ASPET
ASPET's Career Center resources help you look for jobs in your area of specialty and proactively manage your career goals. Don’t forget to view our current job listings!
Non-Tenure Track Associate/Assistant Professor in Pharmaceutical Sciences — Texas Tech University Health Sciences Center, School of Pharmacy, Abilene, TX
Assistant/Associate Professor of Pharmacology — High Point University, High Point, NC
Faculty — Pharmacology & Toxicology - MCPHS University, Boston, MA
Assistant/Associate Teaching Professor — University of Missouri, Kansas City, MO
ASPET
If your department has a job opening, consider posting your job on the ASPET Career Center. Not only will your job be seen by members visiting our website, but we also market our jobs to members through our Newsbrief and to our over 1,700 LinkedIn Group members.
CLICK HERE FOR MORE JOBS
National Institutes of Health
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin, a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.
READ MORE
Science Daily
New knowledge about the mechanism of specific protein complexes in the body could help in the development of better drugs for the treatment of diseases such as cancer and Alzheimer's, according to research led by the University of Leicester. The team focused on understanding the structure and function of large protein complexes in the body that are involved in the regulation of gene expression called corepressor complexes.
READ MORE
Medical Xpress
A new strategy for engineering protein fusions — to make specific cell-targeted drugs without side effects — could enable a safer, more potent class of protein drugs. A research team designed a better variant of the widely-used drug erythropoietin, showing how rational design can improve in vivo efficacy and safety of protein therapeutics, reduce potential side effects and also accelerate new drug development.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
